Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Developments with targeted enzymes in cancer therapy.

K D Bagshawe1, S K Sharma, P J Burke

  • 1Department of Medical Oncology, Imperial College of Medicine, Charing Cross campus London, W6 8RP, UK. k.bagshawe@cxwms.ac.uk

Current Opinion in Immunology
|October 6, 1999
PubMed
Summary

Polymer-drug conjugates enhance cancer therapy by delivering enzymes to tumors, activating prodrugs into cytotoxic agents. This approach reduces immunogenicity and allows targeted cancer treatment with improved efficacy.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Editorial.

Journal of the Royal College of Physicians of London·2019
Same author

The management of high-risk gestational trophoblastic tumours (GTT).

International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics·2018
Same author

Radioimmunoassays [abridged].

Proceedings of the Royal Society of Medicine·2010
Same author

Chemotherapy in breast cancer.

Proceedings of the Royal Society of Medicine·2010
Same author

Descriptive epidemiological features of cases of bovine spongiform encephalopathy born after July 31, 1996 in Great Britain.

The Veterinary record·2010
Same author

Penicillin prophylaxis in acute rheumatism.

Lancet (London, England)·2010

Area of Science:

  • Oncology
  • Biotechnology
  • Drug Delivery

Background:

  • Enzyme-directed cancer therapy has evolved significantly.
  • Antibody-directed enzyme/prodrug therapy is a key area of advancement.
  • Polymer-based enzyme delivery offers new therapeutic strategies.

Purpose of the Study:

  • To explore the use of polymers for enzyme delivery to solid tumors.
  • To investigate the potential of polymer-enzyme conjugates in cancer treatment.
  • To evaluate methods for targeted activation of prodrugs within tumors.

Main Methods:

  • Utilizing methoxypolyethylene glycol (MPEG) to create enzyme conjugates.
  • Employing polymer-enzyme conjugates for targeted prodrug activation.
  • Investigating the use of enzyme-activated rescue agents for selective tumor targeting.

Related Experiment Videos

Main Results:

  • MPEG-enzyme conjugates demonstrate reduced immunogenicity, enabling repeat treatments.
  • Polymer-delivered enzymes can convert prodrugs (e.g., CB1954) into potent cytotoxic agents.
  • Tumor-specific enzyme activity can enable prolonged antimetabolite action by degrading rescue agents.

Conclusions:

  • Polymer-based enzyme delivery systems represent a promising strategy for cancer therapy.
  • This approach allows for targeted activation of prodrugs and enhanced therapeutic efficacy.
  • Further development of enzyme delivery systems can improve cancer treatment outcomes.